**Author details**

Maria-de-Lourdes Irigoyen-Coria1 \*, Vilma-Carolina Bekker-Mendez<sup>2</sup> , Maria-Isabel Leyva-Carmona3 , Cecilia Rosel-Pech<sup>2</sup> , Samuel Moreno-Olivares4 and David Solis-Hernandez5

1 Lindavista Integral Specialized Clinics Laboratory (LCEIL), Mexican Social Security Institute (IMSS), Mexico City, Mexico

2 Biomedical Research Unit Hospital of CMN Infectology "La Raza" IMSS, Mexico City, Mexico

3 Institute of Social Security and Services of State Workers (ISSSTE), Mexico City, Mexico

4 Mexican Social Security Institute (IMSS), Mexico City, Mexico

5 National Autonomous University of Mexico (UNAM) and Lindavista Integral Specialized Clinics Laboratory (LCEIL), Mexico City, Mexico

\*Address all correspondence to: luluirigoyen@yahoo.es

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**167**

jlb.0212067

*Eosinophilic Disorders: Extrinsic and Intrinsic Immune Response, New Diagnostic Perspectives…*

2009;**61**(4):313-326. Available from: https://www.medigraphic.com/pdfs/ revinvcli/nn-2009/nn094i.pdf

[9] Kita H. Eosinophils: Multifaceted biological properties and roles health and disease. Immunological Reviews. 2011;**242**:161-177. DOI: 10.1111/j.

[10] Gotlib J. World Health Organization defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. American Journal of

1600-065X.2011.01026.x

Hematology. 2017;**92**:1242-1259

[11] Simon D et al. Eosinophilic disorders. The Journal of Allergy and Clinical Immunology. 2007;**119**:1291-1300

[12] Grzegorz H et al. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes. Polskie Archiwum Medycyny Wewnętrznej. 2011;**121**:1-2

[14] Busse WW, Ring J, Huss-Marp J, Kahn JE. A review of treatment with mepolizumab, an anti–IL-5 mAb, in hypereosinophilic syndromes and asthma. The Journal of Allergy and Clinical Immunology.

[15] Vardiman J, Bennett J, Bain B, Brunning RTJ. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors.

[16] Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, et al. Contemporary consensus proposal on criteria and classification

[13] Fichman L. Síndrome Hipereosinofilico. Hema. 2007;**11**(3):220-242

2010;**125**(4):803-813

2008. pp. 80-81

*DOI: http://dx.doi.org/10.5772/intechopen.89229*

[1] Davoine F, Lacy P. Eosinophil cytokines and growth factors:

[2] Lorente F, Pellegrini J, de Arriba S. Immune Function of the Eosinophil in Health and Disease XXXIX Congress of the Spanish Society of Clinical Immunology and Pediatric Allergology. Spain: Spanish Pediatric

Association (AEP); 2015

Emerging roles in immunity. Frontiers in Immunology. 2014;**10**:570. DOI: 10.3389/fimmu.2014. 00570

[3] Buckland K, Matin MC Traductor. Eosinophils [Internet]. Available from: http://inmunologia.eu/celulasinmunologia-en-un-mordisco/ eosinofilos [Accessed on: 18-06-2019]

[4] Dagmar S, Hans-Uwe S. Eosinophilic disorders. The Journal of Allergy and Clinical Immunology. 2007;**119**(6):1291- 1300. DOI: 10.1016/j.jaci.2007.02.010

[5] Bailon F, Huerta L, Gutierrez H. Differential diagnosis of peripheral eosinophilia and new treatment options. Pediatric Allergy, Asthma and Immunology. 2012;**21**(2):63- 71. Available from: https://www. medigraphic.com/cgi-bin/new/ resumen.cgi?IDARTICULO=37666

[6] Muniz VS, Weller PF, Neves JS. Eosinophil crystalloid granules: Structure, function, and beyond. Journal of Leukocyte Biology. 2012;**92**:281-288. DOI: 10.1189/

[7] Rothenberg ME, Hogaan SP. The eosinophil. Annual Review of Immunology. 2006;**24**:147-174.

[8] Mora N, Rosales C. Fc receptor functions defense mechanisms and immune regulation. Revista

DOI: 10.1146/annurev. immunol.24.021605.090720

de Investigación Clínica.

**References**

*Eosinophilic Disorders: Extrinsic and Intrinsic Immune Response, New Diagnostic Perspectives… DOI: http://dx.doi.org/10.5772/intechopen.89229*
